Celltrion Healthcare Co., Ltd. (KOSDAQ:A091990) announces a share repurchase program. Under the program, the company will repurchase up to 630,000 shares. The purpose of the share repurchase program is to stabilize the share price and enhance shareholders value.

The repurchase program will continue until May 18, 2022. As of February 17, 2022, the company had no shares in treasury within scope available for dividend and had 2,410,059 shares in treasury through other repurchase.